Latest news with #shareholding
Globe and Mail
2 days ago
- Business
- Globe and Mail
Jane Silverstone Segal Increases Number of Shares of DAVIDsTEA Inc. Under Her Control
MONTREAL, June 20, 2025 (GLOBE NEWSWIRE) -- Jane Silverstone Segal, Chair of the Board of Directors of DAVIDsTEA Inc. (' DAVIDsTEA ') (TSXV: DTEA), announces that on June 20, 2025, she received shares of Rainy Day Investments Ltd. (' RDI ') by way of bequest from her late husband Mr. Herschel Segal, as a result of which Jane Silverstone Segal has voting control of RDI. RDI owns 12,012,538 common shares of DAVIDsTEA, representing 44.51% of DAVIDsTEA's issued and outstanding common shares, which shares are now controlled by Jane Silverstone Segal. Immediately prior to the transfer of shares described above, Jane Silverstone Segal held 127,087 common shares of DAVIDsTEA, representing 0.47% of its 26,985,738 issued and outstanding common shares. Immediately after the transfer of shares described above, Mrs. Segal holds or exercises control, directly or indirectly, over 12,139,625 common shares, representing 44.99% of DAVIDsTEA's issued and outstanding common shares. As a result of the transfer of shares described above, Mrs. Segal's holdings of DAVIDsTEA's common shares increased to 44.99% from 0.47%. The late Mr. Herschel Segal also held 1,523 common shares of DAVIDsTEA directly, representing 0.006% of the issued and outstanding shares. The 1,523 shares will be transferred to Jane Silverstone Segal by way of bequest in due course, following which she will hold or exercise control, directly or indirectly, over 12,141,148 common shares, representing 44.99% of DAVIDsTEA's issued and outstanding common shares. In accordance with applicable securities laws, Mrs. Segal may, from time to time and at any time, acquire additional DAVIDsTEA shares and/or other equity, debt or other securities or instruments (collectively, ' Securities ') of DAVIDsTEA in the open market or otherwise, and Mrs. Segal reserves the right to dispose of any or all of her Securities in the open market or otherwise at any time and from time to time, and to engage in similar transactions with respect to the Securities, the whole depending on market conditions, the business and prospects of the DAVIDsTEA and other relevant factors. A copy of an early warning report filed by Jane Silverstone Segal in connection with the transfer described above is available on SEDAR+ under DAVIDsTEA's profile. This news release is issued under the early warning provisions of Canadian securities legislation.
Yahoo
14-06-2025
- Business
- Yahoo
Kuros Biosciences AG (VTX:KURN) surges 4.9%; individual investors who own 59% shares profited along with insiders
Significant control over Kuros Biosciences by individual investors implies that the general public has more power to influence management and governance-related decisions 41% of the business is held by the top 25 shareholders 24% of Kuros Biosciences is held by insiders Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. If you want to know who really controls Kuros Biosciences AG (VTX:KURN), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 59% to be precise, is individual investors. In other words, the group stands to gain the most (or lose the most) from their investment into the company. Individual investors gained the most after market cap touched CHF995m last week, while insiders who own 24% also benefitted. In the chart below, we zoom in on the different ownership groups of Kuros Biosciences. Check out our latest analysis for Kuros Biosciences Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing. As you can see, institutional investors have a fair amount of stake in Kuros Biosciences. This can indicate that the company has a certain degree of credibility in the investment community. However, it is best to be wary of relying on the supposed validation that comes with institutional investors. They too, get it wrong sometimes. It is not uncommon to see a big share price drop if two large institutional investors try to sell out of a stock at the same time. So it is worth checking the past earnings trajectory of Kuros Biosciences, (below). Of course, keep in mind that there are other factors to consider, too. Hedge funds don't have many shares in Kuros Biosciences. The company's largest shareholder is C. Oomen, with ownership of 22%. Meanwhile, the second and third largest shareholders, hold 3.8% and 3.3%, of the shares outstanding, respectively. A deeper look at our ownership data shows that the top 25 shareholders collectively hold less than half of the register, suggesting a large group of small holders where no single shareholder has a majority. Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. As far as we can tell there isn't analyst coverage of the company, so it is probably flying under the radar. The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO. Most consider insider ownership a positive because it can indicate the board is well aligned with other shareholders. However, on some occasions too much power is concentrated within this group. Our information suggests that insiders maintain a significant holding in Kuros Biosciences AG. Insiders own CHF234m worth of shares in the CHF995m company. That's quite meaningful. Most would say this shows a good degree of alignment with shareholders, especially in a company of this size. You can click here to see if those insiders have been buying or selling. The general public -- including retail investors -- own 59% of Kuros Biosciences. This size of ownership gives investors from the general public some collective power. They can and probably do influence decisions on executive compensation, dividend policies and proposed business acquisitions. We can see that Private Companies own 3.8%, of the shares on issue. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company. It's always worth thinking about the different groups who own shares in a company. But to understand Kuros Biosciences better, we need to consider many other factors. Case in point: We've spotted 1 warning sign for Kuros Biosciences you should be aware of. If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data. NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Wall Street Journal
04-06-2025
- Business
- Wall Street Journal
Carrefour Sells Minority Stake in Shopping Center Owner Carmila for $194.5 Million
Carrefour said it sold a 7% shareholding in shopping center owner Carmila CARM -5.37%decrease; red down pointing triangle for around 171 million euros ($194.5 million) as part of a strategic review of its portfolio. The French grocer said Wednesday that it completed the sale of 9,866,421 shares in Carmila via an accelerated book-build process. Carrefour said it plans to remain Carmila's main shareholder and that the divestment won't result in any change to the existing partnerships, mandates and service agreements between the two companies. During the share placement, Carmila itself bought back around 1 million euros worth of its own shares to complete its share-buyback program, Carrefour added. Write to Maitane Sardon at
Reuters
26-05-2025
- Business
- Reuters
Kenya's government to sell more of its stake in Safaricom, finance minister says
NAIROBI, May 26 (Reuters) - Kenya's government plans to sell more of its shareholding in telecom operator Safaricom ( opens new tab, Finance Minister John Mbadi was cited as saying in Kenyan newspaper Business Daily on Monday. The government aims to raise 149 billion shillings ($1.16 billion) in the 2025/26 financial year through the sale of stakes in companies it has share in, including selling more of its ownership of Safaricom, Mbadi told the Business Daily in an interview. At present, the government owns a 35% stake in the operator after it sold a 25% stake in it via an initial public offering in 2008. ($1 = 129.0000 Kenyan shillings)
Yahoo
23-05-2025
- Business
- Yahoo
Major shareholder notification – BlackRock, Inc.
GN Store Nord A/S hereby announces that on May 22, 2025, pursuant to Section 38(1) and Section 39(1) of the Danish Capital Markets Act, it received a notification from BlackRock, Inc. stating that on May 21, 2025, BlackRock, Inc. increased its aggregate direct and indirect holding of shares and financial instruments, cf. Section 38 and Sections 39(2)(1) and (2) of the Danish Capital Markets Act, to above 5% of the share capital and voting rights in GN Store Nord A/S. For further information, please contact: Investor RelationsRune Sandager +45 45 75 92 57 Media Relations Steen Frentz Laursen +45 20 65 34 20 About GN GN facilitates communication between people through intelligent hearing, audio, video, and gaming technology. Inspired by people and driven by our passion for innovation, we leverage technologies to deliver unique user experiences that bring people closer through the power of sound and vision. GN was founded more than 150 years ago with a vision to connect the world. Today, we proudly honor that legacy with our world-leading expertise in the human ear, audio, video and speech, wireless technologies, software, miniaturization, and collaboration with leading technology partners. GN's solutions are marketed by the brands ReSound, SteelSeries, Jabra, Beltone, Interton, BlueParrott, Danavox and FalCom in 100 countries. Founded in 1869, the GN Group employs 7,000 people and is listed on Nasdaq Copenhagen ( Visit our homepage - and connect with us on LinkedIn, Facebook and X.
